JMML patient-derived iPSCs harboring mutation in PTPN11 showed increased bias towards myeloid differentiation and increased Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) hypersensitivity [69]. The gene discussed is CSF2; the disease is juvenile myelomonocytic leukemia.